Enterococcus gallinarum carrying the vanA gene cluster: First report in Brazil

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 11, 2004, Pages 1669-1671

  Camargo, I L B C ^a   Barth, A L ^b   Pilger, K ^b   Seligman, B G S ^b   Machado, A R L ^b   Darini, A L C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Enterococcus gallinarum; Resistance; VanA phenotype; Vancomycin

Indexed keywords

FUSIDIC ACID; GLYCOPEPTIDE; PROTEIN VANA; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BRAZIL; ENTEROCOCCUS GALLINARUM; GENE CLUSTER; GENE IDENTIFICATION; GENE TRANSFER; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPECIES DIFFERENCE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROCOCCUS GALLINARUM; POSIBACTERIA;

EID: 9244244805     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004001100012     Document Type: Article

References (18)

1. Uttley AHC, Collins CH, Naidoo J & George RC (1988). Vancomycin-resistant enterococci. Lancet, 1: 57-58.
2. Leclercq R, Derlot E, Duval J & Courvalin P (1988). Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New England Journal of Medicine, 319: 157-161.
3. Dalla Costa LM, Souza DC, Martins LTF, Zanella RC, Brandileone MC, Bokermann S, Sader HS & Souza APHM (1998). Vancomycin-resistant Enterococcus faecium: First case in Brazil. Brazilian Journal of Infectious Diseases, 3: 160-163.
4. Dalla Costa LM, Reynolds PE, Souza HA, Souza DC, Palepou MF & Woodford N (2000). Characterization of a divergent VanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil. Antimicrobial Agents and Chemotherapy 44: 3444-3446.
5. Cereda RF, Gales AC, Silbert S, Jones RN & Sader HS (2002). Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil. Infection Control and Hospital Epidemiology, 23: 19-22.
6. Zanella RC, Valdetaro F, Lovgren M, Tyrrel GJ, Bokermann S, Almeida SCG, Vieira VSD & Brandileone MCC (1999). First confirmed case of a vancomycin-resistant Enterococcus faecium with Van A phenotype from Brasil: isolation from a meningitis case in São Paulo. Microbial Drug Resistance, 5: 159-162.
7. Woodford N (1998). Glycopeptide-resistant enterococci: a decade of experience. Journal of Medical Microbiology, 47: 849-862.
8. Liassine N, Frei R, Jan I & Auckenthaler R (1998). Characterization of glycopeptide-resistant Enterococci from a Swiss Hospital. Journal of Clinical Microbiology, 36: 1853-1858.
9. Schooneveldt JIM, Marriott RK & Nimmo GR (2000). Detection of vanB determinant in Enterococcus gallinarum in Australia. Journal of Clinical Microbiology, 38: 3902.
10. Biavasco F, Paladini C, Vignaroli C, Foglia G, Manso E & Varaldo PE (2001). Recovery from a single blood culture of two Enterococcus gallinarum isolates carrying both vanC-1 and vanA cluster genes and differing in glycopeptide susceptibility. European Journal of Clinical Microbiology and Infectious Diseases, 20: 309-314.
11. Dutka-Malen S, Blaimont B, Wauters G & Courvalin P (1994). Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrobial Agents and Chemotherapy, 7: 1675-1677.
12. Lu JJ, Wu JC, Chiueh TS, Perng CL, Chi WM & Lee WH (2000). Characterization of a highly glycopeptide-resistant Enterococcus gallinarum isolate. Journal of the Formosan Medical Association, 4: 305-310.
13. NCCLS (2002). Performance Standards for Antimicrobial Susceptibility Testing. Twelfth Informational Supplement M100-S12. National Committee for Clinical Laboratory Standards, Villanova, PA, USA.
14. Woodford N, Morrison D, Johnson AP, Briant V, George RC & Cookson B (1993). Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant Enterococci. Journal of Clinical Microbiology, 31: 653-658.
15. Woodford N, Morrison D, Johnson AP, Bateman AC, Hasting JGM & Cookson B (1995). Plasmid-mediated vanB glycopeptide resistance in enterococci. Microbial Drug Resistance, 1: 235-240.
16. Molinas AM, Depardieu F & Courvalin P (1993). Characterization of Tn1546, a Tn 3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. Journal of Bacteriology, 175: 117-127.
17. Woodford N, Watson AP & Chadwick PR (1997). Investigation by long PCR of genetic elements mediating VanA glycopeptide resistance in enterococci from uncooked meat in South Manchester. In: Horaud T, Bouvet A, Leclerq R, de Montelos H & Sicard M (Editors), Streptococci and the Host 1997. Plenum Press, New York, 406-412.
18. Tremlett CH, Brown DFJ & Woodford N (1999). Variation in structure and location of VanA glycopeptide resistance elements among enterococci from a single patient. Journal of Clinical Microbiology 17: 818-820.